LLY Mar 2025 500.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:23PM EDT. Market open.
Loading interactive chart…
- Investor's Business Daily
Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug
Hims stock popped Monday after the FDA reportedly said it would reconsider its decision to bar compounders from selling knockoff tirzepatide.
- Investor's Business Daily
Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A Downgrade
Amgen stock dipped Monday after an analyst downgraded shares, saying the opportunity for its weight-loss drug is already baked into the stock.
- GuruFocus.com
Hims & Hers Stock Soars 7% as FDA Reconsiders Limits on Compounded Weight-Loss Drugs
FDA Review Sparks Hope for Continued Access to Affordable Alternatives Amid Weight-Loss Drug Shortage
© 2024 Yahoo. All rights reserved.